{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:05:16Z","timestamp":1775322316411,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor and Welfare of Japan"},{"name":"Ministry of Education, Culture and Technology, Japan","award":["24791748"],"award-info":[{"award-number":["24791748"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.heares.2015.12.017","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T07:01:57Z","timestamp":1450767717000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Dehydration effects of a V2 antagonist on endolymphatic hydrops in guinea pigs"],"prefix":"10.1016","volume":"332","author":[{"given":"Naoya","family":"Egami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Kakigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3608-0973","authenticated-orcid":false,"given":"Tatsuya","family":"Yamasoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2015.12.017_bib1","doi-asserted-by":"crossref","first-page":"F461","DOI":"10.1152\/ajprenal.1993.265.3.F461","article-title":"Aquaporins: a family of water channel proteins","volume":"265","author":"Agre","year":"1993","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.heares.2015.12.017_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1288\/00005537-198805000-00001","article-title":"Vestibular function in experimental endolymphatic hydrops","volume":"98","author":"Andrews","year":"1988","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heares.2015.12.017_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1749-4486.2005.01107.x","article-title":"The association of antidiuretic hormone levels with an attack of M\u00e9ni\u00e8re's disease","volume":"30","author":"Aoki","year":"2005","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.heares.2015.12.017_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-96-4-413","article-title":"Role of vasopressin in abnormal water excretion in cirrhotic patients","volume":"96","author":"Bichet","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heares.2015.12.017_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/clc.4960180704","article-title":"Electrolyte disturbances in chronic heart failure: metabolic and clinical aspects","volume":"18","author":"Cas","year":"1995","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.heares.2015.12.017_bib6","doi-asserted-by":"crossref","first-page":"F29","DOI":"10.1152\/ajprenal.2000.278.1.F29","article-title":"Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist\/antagonist treatment","volume":"278","author":"Christensen","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.heares.2015.12.017_bib7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Non-peptide arginine-vasopressin antagonists: the vaptans","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.heares.2015.12.017_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/labinvest.2013.91","article-title":"Morphological and functional changes in a new animal model of M\u00e9ni\u00e8re's disease","volume":"93","author":"Egami","year":"2013","journal-title":"Lab. Investig."},{"key":"10.1016\/j.heares.2015.12.017_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1751-0813.2000.tb10497.x","article-title":"Effects of an oral vasopressin receptor antagonist (OPC-31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone","volume":"78","author":"Fleeman","year":"2000","journal-title":"Aust. Veterinary J."},{"key":"10.1016\/j.heares.2015.12.017_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0378-5955(98)00009-4","article-title":"Expression of mRNA encoding vasopressin V1a, vasopressin V2, and ANP-B receptors in the rat cochlea","volume":"117","author":"Furuta","year":"1998","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.12.017_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00016489950181936","article-title":"Expression of mRNAs encoding hormone receptors in the endolymphatic sac of the rat","volume":"119","author":"Furuta","year":"1999","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.heares.2015.12.017_bib12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) investigators. Short-term clinical effects of EVEREST clinical status trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.heares.2015.12.017_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S0022215100003947","article-title":"Observations on the pathology of Meniere's syndrome","volume":"53","author":"Hallpike","year":"1938","journal-title":"J.\u00a0Laryngol. Otol."},{"key":"10.1016\/j.heares.2015.12.017_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/00016489.2010.541940","article-title":"Vasopressin in definite Meniere's disease with positive electrocochleographic findings","volume":"131","author":"Hornibrook","year":"2011","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.heares.2015.12.017_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2460\/javma.1986.189.09.1040","article-title":"Xylazine-ketamine-induced anesthesia in rats and its antagonism by yohimbine","volume":"189","author":"Hsu","year":"1986","journal-title":"J.\u00a0Am. Vet. Med. Assoc."},{"key":"10.1016\/j.heares.2015.12.017_bib16","first-page":"343","article-title":"Membranous hydrops in the inner ear of the guinea pig after the obliteration of the endolymphatic sac","volume":"27","author":"Kimura","year":"1965","journal-title":"Pract. Oto Rhino Laryngologica"},{"key":"10.1016\/j.heares.2015.12.017_bib17","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/00001756-199707070-00038","article-title":"Vasopressin and oxytocin receptor mRNAs are expressed in the rat inner ear","volume":"8","author":"Kitano","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.heares.2015.12.017_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00001756-199904260-00009","article-title":"Regulation of inner ear fluid in the rat by vasopressin","volume":"10","author":"Kitano","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.heares.2015.12.017_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1267\/ahc.34.229","article-title":"Endolymphatic hydrops by administration of vasopressin in the rat","volume":"34","author":"Kitano","year":"2001","journal-title":"Acta Histochem. Cytochem."},{"key":"10.1016\/j.heares.2015.12.017_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s004240050731","article-title":"The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear","volume":"436","author":"Kumagami","year":"1998","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.heares.2015.12.017_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3109\/00016489209137456","article-title":"Ischemia of the endolymphatic sac","volume":"112","author":"Lee","year":"1992","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.heares.2015.12.017_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0378-5955(88)90056-1","article-title":"Cochlear and vestibular functions of the rat after obliteration of the endolymphatic sac","volume":"36","author":"Manni","year":"1988","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.12.017_bib23","first-page":"F400","article-title":"Dehydration reverses vasopressin antagonist-induced diuresis and aquaporin-2 downregulation in rats","volume":"275","author":"Marples","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.heares.2015.12.017_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00129492-200501000-00013","article-title":"Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?","volume":"26","author":"Merchant","year":"2005","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.heares.2015.12.017_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-5955(02)00452-5","article-title":"Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Meniere's disease","volume":"170","author":"Mhatre","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.12.017_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/00480169.2001.36229","article-title":"Renal actions of the alpha 2-adrenoceptor agonist, xylazine, in the anaesthetised rat","volume":"49","author":"Miller","year":"2001","journal-title":"N.\u00a0Z. Vet. J."},{"key":"10.1016\/j.heares.2015.12.017_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: from molecules to medicine","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heares.2015.12.017_bib28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/00016480802441754","article-title":"Expression of aquaporins, vasopressin type 2 receptor, and Na+\u208bK+\u208bCl\u207b cotransporters in the rat endolymphatic sac","volume":"129","author":"Nishimura","year":"2009","journal-title":"Acta Oto-laryngologica"},{"key":"10.1016\/j.heares.2015.12.017_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.heares.2009.09.011","article-title":"Expression of aquaporins and vasopressin type 2 receptor in the stria vascularis of the cochlea","volume":"260","author":"Nishioka","year":"2010","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.12.017_bib30","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI116881","article-title":"Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men","volume":"92","author":"Ohnishi","year":"1993","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heares.2015.12.017_bib31","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma","volume":"52","author":"Robertson","year":"1973","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heares.2015.12.017_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.otc.2010.05.007","article-title":"Endolymphatic hydrops: pathophysiology and experimental models","volume":"43","author":"Salt","year":"2010","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.heares.2015.12.017_bib33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00001756-200207020-00011","article-title":"Aquaporin-2 regulation by vasopressin in the rat inner ear","volume":"13","author":"Sawada","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.heares.2015.12.017_bib34","first-page":"393","article-title":"Paradoxes of body fluid volume regulation in health and disease: a unifying hypothesis","volume":"164","author":"Schrier","year":"1993","journal-title":"West. J. Med."},{"key":"10.1016\/j.heares.2015.12.017_bib35","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1172\/JCI119098","article-title":"Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist","volume":"98","author":"Serradeil-Le Gal","year":"1996","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heares.2015.12.017_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/mlg.0b013e318031c802","article-title":"Expressions of aquaporin-2, vasopressin type 2 receptor, transient receptor potential channel vanilloid (TRPV)1, and TRPV4 in the human endolymphatic sac","volume":"117","author":"Taguchi","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heares.2015.12.017_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3757\/jser.52.Suppl-9_139","article-title":"Epidural electrocauterization of endolymphatic sac","volume":"9","author":"Takeda","year":"1993","journal-title":"Equibrium Res."},{"key":"10.1016\/j.heares.2015.12.017_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/00016489509121909","article-title":"Antidiuretic hormone (ADH) and endolymphatic hydrops","volume":"519","author":"Takeda","year":"1995","journal-title":"Acta Oto-Laryngologica. Stockh."},{"key":"10.1016\/j.heares.2015.12.017_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000265113","article-title":"Hormonal aspects of M\u00e9ni\u00e8re's disease on the basis of clinical and experimental studies","volume":"71","author":"Takeda","year":"2009","journal-title":"ORL"},{"key":"10.1016\/j.heares.2015.12.017_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(99)00180-X","article-title":"Endolymphatic hydrops induced by chronic administration of vasopressin","volume":"140","author":"Takeda","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.12.017_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.heares.2006.05.001","article-title":"A\u00a0comparison of dehydration effects of V2-antagonist (OPC-31260) on the inner ear between systemic and round window applications","volume":"21","author":"Takeda","year":"2006","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.12.017_bib42","first-page":"807","article-title":"Localization of aquaporins 1, 2, and 3 and vasopressin type 2 receptor in the mouse inner ear","volume":"132","author":"Takumida","year":"2012","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.heares.2015.12.017_bib43","first-page":"2310","article-title":"Uber die pathologische Veranderung bei einem Meniere-Kranken","volume":"44","author":"Yamakawa","year":"1938","journal-title":"J.\u00a0Otorhinolaryngol Soc Jpn"},{"key":"10.1016\/j.heares.2015.12.017_bib44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.1992.tb09058.x","article-title":"Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist","volume":"105","author":"Yamamura","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heares.2015.12.017_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595515302045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595515302045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T22:10:58Z","timestamp":1748729458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595515302045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":45,"alternative-id":["S0378595515302045"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2015.12.017","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dehydration effects of a V2 antagonist on endolymphatic hydrops in guinea pigs","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}